9th World Congress on BA/BE Studies and Biowaivers

It’s time to announce “9th World Congress on BA/BE Studies and Biowaivers” held July 17-19, 2017 at Melbourne, Australia. Bioequivalence Congress is a 3-day event offering the Exhibition, at venue to showcase the research and development on emerging technologies and have wider sessions involving Keynote presentation, Oral, YRF ( student presentation), poster, e-poster presentations. This is an excellent platform to intensify collaborations for Professionals Scientific Experts and Industrial Delegates for Pharma field knowledge seekers.

Who to attend:

CEOs, CROs, Directors, Managers and research associates in pharmaceutical industry in the drug or device industries (both innovator and generic)
Academic and Industrial Scientists Associated with Discovery, Formulation and The Delivery of Drugs
Regulatory and Clinical Scientists involved in Drug Development
Researchers, Education providers in Clinical Pharmacy, Pharmacology and Toxicology
Students and Postdoctoral Fellows in All Areas of The Pharmaceutical Sciences
Government Agencies involved in Chemical Safety Assessment
Medical Practitioners Such As Clinical Pharmacologists, Clinical Toxicologists.
Molecular and Cellular Pharmacologists

Confernce Website:
http://bioavailability-bioequivalence.pharmaceuticalconferences.com/asiapacific/